Compare Iovance Biotherapeutics Inc. Common Stock (IOVA) vs Waste Management, Inc. (WM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Iovance Biotherapeutics Inc. Common Stock vs Waste Management, Inc. — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $14.63 (market cap $6.04B), while Waste Management, Inc. trades at $208.63 (market cap $83.98B). The key difference: Waste Management, Inc. is far larger — about 13.9× Iovance Biotherapeutics Inc. Common Stock's market cap, and Waste Management, Inc. pays a 1.8% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and Waste Management, Inc. for 130 Days on average.
| IOVA | WM | |
|---|---|---|
Market Cap | $6.04B | $83.98B |
Volume | 14,805,993 | 2,182,180 |
Sector | Health | Industrials |
52-Week High | $14.82 | $246.51 |
52-Week Low | $1.81 | $196.77 |
Typical Hold Time | 0 Days | 130 Days |
Enterprise Value | $5.97B | $106.78B |
Dividend Yield | — | 1.8% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Waste Management (WM) trades at $208.83, showing minimal daily movement with a slight decline of 0.05%. The stock maintains strong profitability metrics including a 29.83% ROE and 11.12% net margin, though valuation ratios appear elevated with a P/E of 29.72. Recent earnings show mixed performance with two beats and one miss in the last three quarters. Technical indicators suggest a bullish overall signal despite bearish moving averages, with key support at $208 and resistance at $212.
WM demonstrates resilient fundamentals with steady revenue growth and strong cash flow generation, though elevated debt levels and tight liquidity present concerns. Analyst consensus remains positive with 54% buy ratings and no sell recommendations. The company's essential service business model provides defensive characteristics, but investors should monitor debt management and competitive pressures in the waste management sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →About Waste Management, Inc.
Waste Management ranks as the largest integrated provider of traditional solid waste services in the United States, operating approximately 260 active landfills and about 340 transfer stations. The company serves residential, commercial, and industrial end markets and is also a leading recycler in North America.
Read more on WM →
